Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.46 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.46 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | GJA1 | P17302 | 1/20 | 0.45 |
| ▸ | GJB2 | P29033 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | TYR | P14679 | 1/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.43 |
| ▸ | IGF2R | P11717 | 1/20 | 0.41 |
| ▸ | FGF1 | P05230 | 1/20 | 0.41 |
| ▸ | FGF2 | P09038 | 1/20 | 0.41 |
| ▸ | VEGFA | P15692 | 1/20 | 0.41 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CD209 | Q9NNX6 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5971913 | 1.00 | MEN1 (0.50) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| SCHEMBL16004719 | 1.00 | MEN1 (0.50) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| SCHEMBL6900928 | 0.88 | MEN1 (0.50) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| SCHEMBL1389240 | 0.88 | MEN1 (0.50) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| SCHEMBL2139671 | 0.88 | MEN1 (0.50) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| SCHEMBL2139680 | 0.88 | MEN1 (0.50) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| SCHEMBL3188633 | 0.88 | MEN1 (0.50) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| SCHEMBL15254624 | 0.87 | AMY1A (0.49) | MEN1KMT2AL3MBTL1 | |
| SCHEMBL15845156 | 0.87 | AMY1A (0.49) | MEN1KMT2AL3MBTL1 | |
| SCHEMBL23140668 | 0.86 | MEN1 (0.52) | MEN1KMT2ALGALS8LGALS3LGALS4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230346952-A1 | CANNABINOID GLYCOSIDE PRODRUGS AND METHODS OF SYNTHESIS | GRAPHIUM BIOSCIENCES, INC. (US) | 2023-11-02 | — | — | US | claimed |
| US-20230340555-A1 | PRODUCTION OF GLYCOSYLATED CANNABINOIDS | WILLOW BIOSCIENCES, INC. (CA) | 2023-10-26 | — | — | US | claimed |
| US-20220227726-A1 | CANNABINOID GLYCOSIDES AND USES THEREOF | GRAPHIUM BIOSCIENCES, INC. (US) | 2022-07-21 | — | — | US | claimed |
| US-20220168428-A1 | CANNABINOID GLYCOSIDE PRODRUGS AND METHODS OF SYNTHESIS | GRAPHIUM BIOSCIENCES, INC. (US) | 2022-06-02 | — | — | US | claimed |
| WO-2022099078-A1 | PRODUCTION OF GLYCOSYLATED CANNABINOIDS | WILLOW BIOSCIENCES, INC. (CA) | 2022-05-12 | — | — | WO | claimed |
| US-11207414-B2 | Cannabinoid glycoside prodrugs and methods of synthesis | GRAPHIUM BIOSCIENCES, INC. (US) | 2021-12-28 | — | — | US | claimed |
| US-20180264122-A1 | Cannabinoid Glycoside Prodrugs and Methods of Synthesis | VITALITY BIOPHARMA, INC. (US) | 2018-09-20 | — | — | US | claimed |
| US-20230346952-A1 | CANNABINOID GLYCOSIDE PRODRUGS AND METHODS OF SYNTHESIS | GRAPHIUM BIOSCIENCES, INC. (US) | 2023-11-02 | — | — | US | disclosed |
| US-20230340555-A1 | PRODUCTION OF GLYCOSYLATED CANNABINOIDS | WILLOW BIOSCIENCES, INC. (CA) | 2023-10-26 | — | — | US | disclosed |
| US-20220227726-A1 | CANNABINOID GLYCOSIDES AND USES THEREOF | GRAPHIUM BIOSCIENCES, INC. (US) | 2022-07-21 | — | — | US | disclosed |
| US-20220168428-A1 | CANNABINOID GLYCOSIDE PRODRUGS AND METHODS OF SYNTHESIS | GRAPHIUM BIOSCIENCES, INC. (US) | 2022-06-02 | — | — | US | disclosed |
| WO-2022099078-A1 | PRODUCTION OF GLYCOSYLATED CANNABINOIDS | WILLOW BIOSCIENCES, INC. (CA) | 2022-05-12 | — | — | WO | disclosed |
| US-11207414-B2 | Cannabinoid glycoside prodrugs and methods of synthesis | GRAPHIUM BIOSCIENCES, INC. (US) | 2021-12-28 | — | — | US | disclosed |
| US-20180264122-A1 | Cannabinoid Glycoside Prodrugs and Methods of Synthesis | VITALITY BIOPHARMA, INC. (US) | 2018-09-20 | — | — | US | disclosed |
| JP-2003220119-A | METHOD FOR PRODUCING CAPSULE | NISSEI KOSAN KK | 2003-08-05 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11207414-B2 | Cannabinoid glycoside prodrugs and methods of synthesis | CNR2, CNR1, UGCG | MEN1 3588/4885KMT2A 1380/4885LGALS8 1390/4885 |
| US-20220227726-A1 | CANNABINOID GLYCOSIDES AND USES THEREOF | CNR2, CNR1, UGCG | MEN1 3544/4885KMT2A 2841/4885LGALS8 1506/4885 |
| US-20230346952-A1 | CANNABINOID GLYCOSIDE PRODRUGS AND METHODS OF SYNTHESIS | CNR2, CNR1, UGCG | MEN1 2797/4885KMT2A 2212/4885LGALS8 2631/4885 |
| US-20220168428-A1 | CANNABINOID GLYCOSIDE PRODRUGS AND METHODS OF SYNTHESIS | CNR2, CNR1, UGCG | MEN1 3588/4885KMT2A 1380/4885LGALS8 1390/4885 |
| US-20180264122-A1 | Cannabinoid Glycoside Prodrugs and Methods of Synthesis | CNR2, CNR1, UGCG | MEN1 3588/4885KMT2A 1380/4885LGALS8 1390/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.